Stock price performance of Aceto Corporation is analyzed for various periods using several stock trading signals. The stock price have dropped -16.83% in the past 12 Weeks but analyzing the 6 month chart of the stock, the price of the stock has managed to drop negative and it has dropped down to -35.54% . Looking at the past 52 week period, the stock price is down -22.96% . Relative price strength is a important factor used by wealth management firms while investing in stocks since the indicator compares the stock performance with the overall market. The relative price strength of Aceto Corporation has a negative value of -6.75 compared to overall market performance. For the current week, the company shares have a recommendation consensus of Buy. The stock has recorded a 20-day Moving Average of 6.35% and the 50-Day Moving Average is 5.24%.The 200 Day SMA reached 8.41%
Based on the Stock Research Aceto Corporation Relative Strength Index signal is in over sold territory with a range of 14.95. Aceto Corporation (NASDAQ:ACET) has tumbled 19.81% during the past week and has dropped 27.05% in the last 4 week period. The stocks are negative as compared to the S&P 500 for the past week with a loss of 19.9%. Aceto Corporation (NASDAQ:ACET) has underperformed the index by 27.7% in the last 4 weeks. Investors should watch out for further signals and trade with caution.
Company has reported several Insider transactions to the SEC, on Jan 18, 2017, Daniel B. Yarosh (director) sold 891 shares at 20.69 per share price.On Dec 19, 2016, Terry Kippley (Sr. Vice President) sold 45 shares at 21.50 per share price.On Dec 9, 2016, Douglas A Roth (Sr. Vice President & CFO) sold 5,000 shares at 21.03 per share price.
Aceto Corporation Last issued its quarterly earnings results on Feb 2, 2017. The company reported $0.24 EPS for the quarter, missing the analyst consensus estimate by $ -0.08. Analyst had a consensus of $0.32. The company had revenue of $125.60 million for the quarter, compared to analysts expectations of $136.65 million. The companys revenue was down -4.6 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.36 EPS.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Aceto Corporation was Downgraded by First Analysis Sec on Nov 14, 2016 to Equal-Weight, Price Target of the shares are set at $21.
Aceto Corporation (NASDAQ:ACET) stock ended Friday session in the red zone in a volatile trading. The stock closed down 3.2 points or 16.96% at $15.67 with 2,993,703 shares getting traded. Post opening the session at $17, the shares hit an intraday low of $15.44 and an intraday high of $17.34 and the price was in this range throughout the day. The company has a market cap of $472 million and the number of outstanding shares has been calculated to be 30,119,000 shares. The 52-week high of Aceto Corporation (NASDAQ:ACET) is $25.98 and the 52-week low is $15.44.
Aceto Corporation markets, sells and distributes finished dosage form generics, nutraceutical products, pharmaceutical intermediates and active ingredients, agricultural protection products and specialty chemicals. The companys operating segment consists of Human Health, Pharmaceutical Ingredients and Performance Chemicals. Human Health segment supplies raw materials used in the production of nutritional and packaged dietary supplements. It markets and distributes its generic prescription and over the counter pharmaceutical products. Pharmaceutical Ingredients segment offers active pharmaceutical ingredients and pharmaceutical intermediates. Performance Chemicals segment provides specialty chemicals. It serves chemical, agricultural, human health and pharmaceutical industries. The company operates primarily in United States, Europe, and Asia. Aceto Corporation and is headquartered in Port Washington, New York.